Milly Kitty Toor

Milly Kitty Toor is senior director, commercial development, at Alumis. Milly joined Alumis from Bristol Myers Squibb / Myokardia, where she served as director, HCP marketing leading brand strategy and market development for mavacamten’s launch. Prior to joining MyoKardia, Milly held roles of increasing responsibility at Gilead and ZS Associates for over 10 years with focus on go to market and portfolio strategy. Milly has global healthcare experience as she worked extensively in Europe and did her MBA at HHL (Leipzig Graduate School of Management).